Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study for the Safety and Efficacy of Intravenous Infusion of NGGT006 in Treatment of Refractory Hypercholesterolemia

NCT06293729 is registered in ClinicalTrials.gov with Suzhou Municipal Hospital as lead sponsor.

NCT NCT06293729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study for the Safety and Efficacy of Intravenous Infusion of NGGT006 in Treatment of Refractory Hypercholesterolemia
Lead sponsor
Suzhou Municipal Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 1, 2024
Completion date
March 1, 2029
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia, refractory hypercholesterolemia